JW (Cayman) Therapeutics Co. Ltd (JWCTF)
OTCMKTS · Delayed Price · Currency is USD
0.3070
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST

JWCTF Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
177.75158.22173.86145.730.8-
177.75158.22173.86145.730.8-
Revenue Growth (YoY)
2.79%-9.00%19.32%373.11%--
Cost of Revenue
79.0680.985.6486.9521.75-
Gross Profit
98.6977.3288.2258.769.05-
Selling, General & Admin
215.76260.48253.24370.64372.25244.56
Research & Development
224.02282.99413.62407.82414.4225.22
Other Operating Expenses
-8.54-7.12-8.5-22.53-5.89-1.92
Operating Expenses
431.25536.35658.37755.93780.76467.86
Operating Income
-332.56-459.03-570.15-697.18-771.72-467.86
Interest Expense
-12.41-12.22-12.42-6.79-2.69-0.77
Interest & Investment Income
27.5628.4334.0316.548.33.44
Currency Exchange Gain (Loss)
-15.4-15.6-37.32-158.5414.8428.9
Other Non Operating Income (Expenses)
----51.15-34.84
EBT Excluding Unusual Items
-332.81-458.42-585.86-845.97-700.12-471.13
Gain (Loss) on Sale of Assets
---0.93-0.17-0.12-
Asset Writedown
-284.86-132.26-181.21---
Other Unusual Items
0.050.05---2.09-1,193
Pretax Income
-617.62-590.62-768-846.14-702.33-1,664
Net Income
-617.62-590.62-768-846.14-702.33-1,664
Net Income to Common
-617.62-590.62-768-846.14-702.33-1,664
Shares Outstanding (Basic)
415414412410400132
Shares Outstanding (Diluted)
415414412410400132
Shares Change (YoY)
0.58%0.51%0.35%2.59%203.07%102.92%
EPS (Basic)
-1.49-1.43-1.87-2.06-1.76-12.61
EPS (Diluted)
-1.49-1.43-1.87-2.06-1.76-12.61
Free Cash Flow
-202.73-338.67-410.83-613.6-634.29-385.24
Free Cash Flow Per Share
-0.49-0.82-1.00-1.50-1.59-2.92
Gross Margin
55.52%48.87%50.74%40.33%29.37%-
Operating Margin
-187.09%-290.13%-327.94%-478.49%-2505.82%-
Profit Margin
-347.47%-373.30%-441.74%-580.73%-2280.51%-
Free Cash Flow Margin
-114.05%-214.05%-236.30%-421.13%-2059.57%-
EBITDA
-268.79-391.09-492.69-629.53-738.7-454.04
EBITDA Margin
-151.22%-247.18%-283.39%---
D&A For EBITDA
63.7767.9577.4667.6533.0113.82
EBIT
-332.56-459.03-570.15-697.18-771.72-467.86
EBIT Margin
-187.09%-290.13%----
Advertising Expenses
-97.1848.3977.3970.125.66
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.